BeyondSpring Inc. Revenue from Contract with Customer, Including Assessed Tax
BeyondSpring Inc. (BYSI) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-14
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $0.00.
- BeyondSpring Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $0.00.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-25 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $1.00K 6-K · filed 2024-08-29 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-27 | ||||
| 2023-06-30 | $875.00 6-K · filed 2024-08-29 | $875.00K 6-K · filed 2024-02-02 | |||
| 2022-12-31 | $1.35M 20-F · filed 2023-04-18 | ||||
| 2022-06-30 | $676.00K 6-K · filed 2024-02-02 | ||||
| 2021-12-31 | $338.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $675.00K derived: sum of 2 quarters · filed 2023-04-18 | $1.01M derived: sum of 3 quarters · filed 2023-04-18 | $1.35M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $337.00K 6-K · filed 2021-12-30 | $675.00K derived: sum of 2 quarters · filed 2021-12-30 | $1.01M 6-K · filed 2021-12-30 | $1.19M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-06-30 | $338.00K 6-K · filed 2021-09-10 | $676.00K 6-K · filed 2023-02-28 | $856.00K derived: sum of 3 quarters · filed 2023-04-18 | $856.00K derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-03-31 | $338.00K 6-K · filed 2021-06-16 | $518.00K derived: sum of 2 quarters · filed 2023-04-18 | $518.00K derived: sum of 3 quarters · filed 2023-04-18 | $518.00K derived: sum of 4 quarters · filed 2023-04-18 | |
| 2020-12-31 | $180.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $180.00K derived: sum of 2 quarters · filed 2023-04-18 | $180.00K derived: sum of 3 quarters · filed 2023-04-18 | $180.00K 20-F · filed 2023-04-18 | |
| 2020-09-30 | $0.00 6-K · filed 2021-12-30 | $0.00 derived: sum of 2 quarters · filed 2021-12-30 | $0.00 6-K · filed 2021-12-30 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-09-10 | $0.00 6-K · filed 2021-09-10 | |||
| 2019-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $0.00 derived: sum of 2 quarters · filed 2022-04-14 | $0.00 derived: sum of 3 quarters · filed 2022-04-14 | $0.00 20-F · filed 2022-04-14 | |
| 2019-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | $0.00 derived: sum of 2 quarters · filed 2019-12-18 | $0.00 6-K · filed 2019-12-18 | ||
| 2019-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | $0.00 6-K · filed 2019-09-18 | |||
| 2019-03-31 | $0.00 6-K · filed 2019-07-10 | ||||
| 2018-12-31 | $0.00 20-F · filed 2021-04-30 | ||||
| 2018-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | $0.00 6-K · filed 2018-10-23 | |||
| 2018-03-31 | $0.00 6-K · filed 2018-06-21 | ||||
| 2017-12-31 | $0.00 20-F · filed 2019-04-30 | ||||
| 2017-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | $0.00 6-K · filed 2018-10-23 | |||
| 2017-03-31 | $0.00 6-K · filed 2018-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |